| Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group … OA Cornely, A Alastruey-Izquierdo, D Arenz, SCA Chen, E Dannaoui, ... The Lancet infectious diseases 19 (12), e405-e421, 2019 | 1464 | 2019 |
| Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline AJ Ullmann, JM Aguado, S Arikan-Akdagli, DW Denning, AH Groll, ... Clinical Microbiology and Infection 24, e1-e38, 2018 | 1305 | 2018 |
| Delaying amphotericin B–based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis G Chamilos, RE Lewis, DP Kontoyiannis Clinical Infectious Diseases 47 (4), 503-509, 2008 | 848 | 2008 |
| Zygomycosis in a Tertiary-Care Cancer Center in the Era of Aspergillus-Active Antifungal Therapy: A Case-Control Observational Study of 27 Recent Cases DP Kontoyiannis, MS Lionakis, RE Lewis, G Chamilos, M Healy, ... The Journal of infectious diseases 191 (8), 1350-1360, 2005 | 773 | 2005 |
| Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989-2003) G Chamilos, M Luna, RE Lewis, GP Bodey, R Chemaly, JJ Tarrand, ... haematologica 91 (7), 986-989, 2006 | 657 | 2006 |
| Antifungal drug resistance of pathogenic fungi DP Kontoyiannis, RE Lewis The Lancet 359 (9312), 1135-1144, 2002 | 592 | 2002 |
| Epidemiology of invasive pulmonary aspergillosis among intubated patients with COVID-19: a prospective study M Bartoletti, R Pascale, M Cricca, M Rinaldi, A Maccaro, L Bussini, ... Clinical Infectious Diseases 73 (11), e3606-e3614, 2021 | 506 | 2021 |
| Current concepts in antifungal pharmacology RE Lewis Mayo Clinic Proceedings 86 (8), 805-817, 2011 | 477 | 2011 |
| Mucormycosis caused by unusual mucormycetes, non-Rhizopus,-Mucor, and-Lichtheimia species MZR Gomes, RE Lewis, DP Kontoyiannis Clinical Microbiology Reviews 24 (2), 411-445, 2011 | 443 | 2011 |
| Pharmacology of systemic antifungal agents ESD Ashley, R Lewis, JS Lewis, C Martin, D Andes Clinical infectious diseases 43 (Supplement_1), S28-S39, 2006 | 424 | 2006 |
| How I treat mucormycosis DP Kontoyiannis, RE Lewis Blood, The Journal of the American Society of Hematology 118 (5), 1216-1224, 2011 | 418 | 2011 |
| Predictors of pulmonary zygomycosis versus invasive pulmonary aspergillosis in patients with cancer G Chamilos, EM Marom, RE Lewis, MS Lionakis, DP Kontoyiannis Clinical Infectious Diseases 41 (1), 60-66, 2005 | 402 | 2005 |
| Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study N Singh, AP Limaye, G Forrest, N Safdar, P Munoz, K Pursell, S Houston, ... Transplantation 81 (3), 320-326, 2006 | 393 | 2006 |
| Influence of test conditions on antifungal time-kill curve results: proposal for standardized methods ME Klepser, EJ Ernst, RE Lewis, ME Ernst, MA Pfaller Antimicrobial agents and chemotherapy 42 (5), 1207-1212, 1998 | 380 | 1998 |
| Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic … DP Kontoyiannis, R Hachem, RE Lewis, GA Rivero, HA Torres, J Thornby, ... Cancer 98 (2), 292-299, 2003 | 346 | 2003 |
| Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion PE Verweij, BJA Rijnders, RJM Brüggemann, E Azoulay, M Bassetti, ... Intensive care medicine 46 (8), 1524-1535, 2020 | 337 | 2020 |
| Canal irrigation and local social organization [and comments and reply] RC Hunt, E Hunt, GM Ahmed, JW Bennett, RK Cleek, PEB Coy, TF Glick, ... Current anthropology 17 (3), 389-411, 1976 | 331 | 1976 |
| Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001‐2007) Stable incidence but changing epidemiology of a still frequently lethal … NV Sipsas, RE Lewis, J Tarrand, R Hachem, KV Rolston, II Raad, ... Cancer 115 (20), 4745-4752, 2009 | 311 | 2009 |
| Invasive zygomycosis: update on pathogenesis, clinical manifestations, and management DP Kontoyiannis, RE Lewis Infectious Disease Clinics 20 (3), 581-607, 2006 | 302 | 2006 |
| Aspergillus fumigatus suppresses the human cellular immune response via gliotoxin-mediated apoptosis of monocytes M Stanzani, E Orciuolo, R Lewis, DP Kontoyiannis, SLR Martins, ... Blood 105 (6), 2258-2265, 2005 | 272 | 2005 |
Dimitrios P. Kontoyiannis, MD, ScD, P...University of Texas MD Anderson Cancer Center在 mdanderson.org 的电子邮件经过验证
